IOSP on Nasdaq
Innospec
Specialty chemical company
Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units: The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets.3 It is headquartered in United States.1 Its shares trade on Nasdaq under the symbol IOSP.1 Wikipedia text CC BY-SA 4.0
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Ingevity Corp, BALCHEM CORP or FMC Corporation, or pick any stock.
- TickerIOSP on Nasdaq1
- Industrypetroleum1
- HeadquartersUnited States1
- Websitewww.innospecinc.com
- Incorporated inDE5
- Business address8310 South Valley Highway, Suite 350, Englewood, Co 801125
- Filer categoryLarge accelerated filer5
- Legal formCorporation4
- LEI213800SQBACNY5IWJO684
- StatusActive4
- LEI statusIssued and current4
- Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States4
- Registered withDivision of Corporations, Department of State, 28515324
See how the biggest companies compare on our leaderboards
Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Fuel Specialties brought in 39% of the revenue Innospec broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Fuel Specialties | $695.9M | $701.1M | $701.5M |
| Performance Chemicals | $561.6M | $653.7M | $681.4M |
| Oilfield Services | $691.3M | $490.6M | $395.1M |
Regions
United States brought in 45% of the revenue Innospec broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $1.2B | $1.0B | $951.7M |
| United Kingdom | $857.7M | $823.4M | $793.2M |
| Rest Of World | $199.4M | $288.9M | $379.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue72¢$1.3B
- Research and development3¢$51.0M
- Selling, general and admin16¢$285.1M
- Other costs1¢$18.2M
- Income tax1¢$21.5M
- Profit7¢$116.6M
Out of $1.8B in revenue.8
Where each dollar of operating cash went, fiscal 2025
- Dividends paid31¢$42.4M
- Share buybacks17¢$23.9M
- Kept or used elsewhere52¢$72.0M
Out of $138.3M of cash from operations.8
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $1.8B | $1.8B | $1.9B |
| Cost of goods sold | -$1.3B | -$1.3B | -$1.4B |
| Gross profit | $492.4M | $542.9M | $591.1M |
| Selling, general and administrative | -$285.1M | -$305.3M | -$380.5M |
| Research and development | -$51.0M | -$56.5M | -$49.0M |
| Adjustment to fair value of contingent consideration | $15.9M | -$3.4M | $0 |
| Restructuring charge | -$900.0K | $0 | $0 |
| Impairment of property, plant and equipment | -$22.9M | $0 | $0 |
| Impairment of intangible assets | -$19.1M | $0 | $0 |
| Profit on disposal of property, plant and equipment | $200.0K | $200.0K | $0 |
| Total operating expenses | -$362.9M | -$365.0M | -$429.5M |
| Operating income | $129.5M | $177.9M | $161.6M |
| Other income/(expense), net | -$600.0K | $9.6M | $10.5M |
| Pension scheme settlement charge | $0 | -$155.6M | $0 |
| Interest income/(expense), net | $9.2M | $9.3M | $2.3M |
| Income before income tax expense | $138.1M | $41.2M | $174.4M |
| Income tax expense | -$21.5M | -$5.6M | -$35.3M |
| Net income | $116.6M | $35.6M | $139.1M |
| Basic | $4.69 | $1.43 | $5.60 |
| Diluted | $4.67 | $1.42 | $5.56 |
| Basic | 24.9M shares | 24.9M shares | 24.9M shares |
| Diluted | 25.0M shares | 25.1M shares | 25.0M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.8
| Period ending | 2025-12-31 | 2025-07-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $292.5M | $289.2M | |||
| Trade and other accounts receivable (less allowances of $11.8 million and $11.9 million, respectively) | $342.3M | $341.7M | |||
| Finished goods | $226.3M | $197.9M | |||
| Raw materials | $103.0M | $103.1M | |||
| Total inventories | $329.3M | $301.0M | |||
| Prepaid expenses | $20.1M | $21.0M | |||
| Prepaid income taxes | $13.1M | $3.1M | |||
| Other current assets | $7.3M | $600.0K | |||
| Total current assets | $1.0B | $956.6M | |||
| Net property, plant and equipment | $286.1M | $269.7M | |||
| Operating leases right-of-use assets | $52.7M | $44.8M | |||
| Goodwill | $399.0M | $2.0M | $382.5M | $399.3M | |
| Other intangible assets | $67.7M | $65.4M | |||
| Deferred tax assets | $13.6M | $9.4M | |||
| Pension asset | $0 | $2.4M | |||
| Other non-current assets | $8.7M | $3.9M | |||
| Total assets | $1.8B | $1.7B | |||
| Accounts payable | $174.7M | $163.8M | |||
| Accrued liabilities | $152.3M | $169.1M | |||
| Current portion of operating lease liabilities | $15.9M | $13.9M | |||
| Current portion of plant closure provisions | $4.9M | $5.0M | $4.6M | ||
| Current portion of acquisition-related contingent consideration | $7.0M | $0 | |||
| Current portion of accrued income taxes | $5.3M | $19.6M | |||
| Total current liabilities | $360.1M | $371.4M | |||
| Operating lease liabilities, net of current portion | $36.8M | $31.0M | |||
| Plant closure provisions, net of current portion | $60.2M | $55.3M | $57.0M | ||
| Deferred tax liabilities | $19.1M | $23.5M | |||
| Pension liabilities and post-employment benefits | $13.2M | $13.1M | |||
| Acquisition-related contingent consideration | $1.3M | $20.1M | |||
| Other non-current liabilities | $8.8M | $4.2M | |||
| Total liabilities | $499.5M | $518.6M | |||
| Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares | $300.0K | $300.0K | |||
| Additional paid-in capital | $376.5M | $369.9M | |||
| Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively) | -$115.2M | -$93.0M | |||
| Retained earnings | $1.1B | $1.0B | |||
| Accumulated other comprehensive loss | -$34.7M | -$91.0M | |||
| Total Innospec stockholders' equity | $1.3B | $1.2B | |||
| Non-controlling interest | $6.8M | $4.9M | |||
| Total equity | $1.3B | $1.2B | $1.1B | $1.0B | |
| Total liabilities and equity | $1.8B | $1.7B | |||
| Allowances for doubtful accounts | $11.8M | $11.9M | |||
| Inventory allowances | $40.4M | $34.6M | |||
| Common stock, par value | $0.01 | $0.01 | |||
| Common stock, shares authorized | 40.0M shares | 40.0M shares | |||
| Common stock, shares issued | 29.6M shares | 29.6M shares | 29.6M shares | 29.6M shares | |
| Treasury stock, shares | 4.8M shares | 4.6M shares | 4.7M shares | 4.8M shares |
| Period ending | 2025-12-31 | 2025-07-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $292.5M | $289.2M | |||
| Trade and other accounts receivable (less allowances of $11.8 million and $11.9 million, respectively) | $342.3M | $341.7M | |||
| Finished goods | $226.3M | $197.9M | |||
| Raw materials | $103.0M | $103.1M | |||
| Total inventories | $329.3M | $301.0M | |||
| Prepaid expenses | $20.1M | $21.0M | |||
| Prepaid income taxes | $13.1M | $3.1M | |||
| Other current assets | $7.3M | $600.0K | |||
| Total current assets | $1.0B | $956.6M | |||
| Net property, plant and equipment | $286.1M | $269.7M | |||
| Operating leases right-of-use assets | $52.7M | $44.8M | |||
| Goodwill | $399.0M | $2.0M | $382.5M | $399.3M | |
| Other intangible assets | $67.7M | $65.4M | |||
| Deferred tax assets | $13.6M | $9.4M | |||
| Pension asset | $0 | $2.4M | |||
| Other non-current assets | $8.7M | $3.9M | |||
| Total assets | $1.8B | $1.7B | |||
| Accounts payable | $174.7M | $163.8M | |||
| Accrued liabilities | $152.3M | $169.1M | |||
| Current portion of operating lease liabilities | $15.9M | $13.9M | |||
| Current portion of plant closure provisions | $4.9M | $5.0M | $4.6M | ||
| Current portion of acquisition-related contingent consideration | $7.0M | $0 | |||
| Current portion of accrued income taxes | $5.3M | $19.6M | |||
| Total current liabilities | $360.1M | $371.4M | |||
| Operating lease liabilities, net of current portion | $36.8M | $31.0M | |||
| Plant closure provisions, net of current portion | $60.2M | $55.3M | $57.0M | ||
| Deferred tax liabilities | $19.1M | $23.5M | |||
| Pension liabilities and post-employment benefits | $13.2M | $13.1M | |||
| Acquisition-related contingent consideration | $1.3M | $20.1M | |||
| Other non-current liabilities | $8.8M | $4.2M | |||
| Total liabilities | $499.5M | $518.6M | |||
| Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares | $300.0K | $300.0K | |||
| Additional paid-in capital | $376.5M | $369.9M | |||
| Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively) | -$115.2M | -$93.0M | |||
| Retained earnings | $1.1B | $1.0B | |||
| Accumulated other comprehensive loss | -$34.7M | -$91.0M | |||
| Total Innospec stockholders' equity | $1.3B | $1.2B | |||
| Non-controlling interest | $6.8M | $4.9M | |||
| Total equity | $1.3B | $1.2B | $1.1B | $1.0B | |
| Total liabilities and equity | $1.8B | $1.7B | |||
| Allowances for doubtful accounts | $11.8M | $11.9M | |||
| Inventory allowances | $40.4M | $34.6M | |||
| Common stock, par value | $0.01 | $0.01 | |||
| Common stock, shares authorized | 40.0M shares | 40.0M shares | |||
| Common stock, shares issued | 29.6M shares | 29.6M shares | 29.6M shares | 29.6M shares | |
| Treasury stock, shares | 4.8M shares | 4.6M shares | 4.7M shares | 4.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $116.6M | $35.6M | $139.1M |
| Depreciation and amortization | $43.6M | $43.5M | $39.3M |
| Adjustment to fair value of contingent consideration | -$15.9M | $3.4M | $0 |
| Impairment of property, plant and equipment | $22.9M | $0 | $0 |
| Impairment of intangible assets | $19.1M | $0 | $0 |
| Deferred taxes | -$10.2M | -$39.3M | $3.6M |
| Profit on disposal of property, plant and equipment | -$200.0K | -$200.0K | $0 |
| Non-cash movements of defined benefit pension plans | $2.7M | $151.9M | -$3.3M |
| Stock option compensation | $8.1M | $8.5M | $8.0M |
| Trade and other accounts receivable | $21.6M | $4.3M | -$12.6M |
| Inventories | -$6.6M | -$11.8M | $83.0M |
| Prepaid expenses | $1.8M | -$2.8M | -$4.2M |
| Accounts payable and accrued liabilities | -$32.8M | -$4.5M | -$26.9M |
| Plant closure provisions | -$1.9M | $900.0K | $4.0M |
| Accrued income taxes | -$21.8M | $6.3M | -$25.9M |
| Unrecognized tax benefits | $0 | -$14.8M | $1.4M |
| Other assets and liabilities | -$8.7M | $3.5M | $1.8M |
| Net cash provided by operating activities | $138.3M | $184.5M | $207.3M |
| Capital expenditures | -$50.3M | -$41.4M | -$62.1M |
| Proceeds on disposal of property, plant and equipment | $1.1M | $500.0K | $100.0K |
| Business combinations, net of cash acquired | -$700.0K | -$200.0K | -$34.7M |
| Internally developed software | -$25.2M | -$20.9M | -$15.1M |
| Net cash used in investing activities | -$75.1M | -$62.0M | -$111.8M |
| Non-controlling interest | $1.9M | $2.4M | $0 |
| Repayment of term loan | $0 | $0 | -$2.3M |
| Refinancing costs | $0 | -$300.0K | -$1.4M |
| Dividend paid | -$42.4M | -$38.8M | -$35.1M |
| Issue of treasury stock | $500.0K | $2.1M | $900.0K |
| Repurchase of common stock | -$23.9M | -$700.0K | -$1.1M |
| Net cash used in financing activities | -$63.9M | -$35.3M | -$39.0M |
| Effect of foreign currency exchange rate changes on cash | $4.0M | -$1.7M | $100.0K |
| Net change in cash and cash equivalents | $3.3M | $85.5M | $56.6M |
No quarter-by-quarter statement was filed.
Corporate structure
Innospec sits at the top of its group. 13 entities, 8 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Innospec
- Allspring Global Investments Holdings, LLC Filed SCHEDULE 13G/A on Innospec, latest Oct 7, 2026 (8 filings since Jan 18, 2022)
- DIMENSIONAL FUND ADVISORS LP Filed SCHEDULE 13G on Innospec, latest Jul 14, 2026 (2 filings since Feb 8, 2022)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Innospec, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Innospec, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Innospec, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
- WASATCH ADVISORS LP Filed SCHEDULE 13G/A on Innospec, latest May 13, 2025 (4 filings since Feb 8, 2023)
- BlackRock Filed SCHEDULE 13G/A on Innospec, latest Apr 30, 2025 (6 filings since Jan 26, 2022)
- ROYCE & ASSOCIATES LP Filed SC 13G/A on Innospec, latest Jan 31, 2023 (2 filings since Jan 21, 2022)
- Wells Fargo Filed SC 13G/A on Innospec, latest Dec 8, 2021 (2 filings since Nov 10, 2021)
- Innospec Englewood, Colorado, United States
- Innospec Active Chemicals LLC (USA) Innospec Deutschland GmbH (Germany) Innospec Finance Limited (U.K.) Innospec Finance U.S. LLC (USA) Innospec France SA Subsidiary · France
- Innospec Chemicals (Shanghai) Limited Subsidiary · China
- Innospec Chemicals Beijing Limited Subsidiary · China
- Innospec Do Brasil Limited Subsidiary · Brazil
- INNOSPEC FINANCE LIMITED Subsidiary · Ellesmere Port, United Kingdom
- INNOSPEC FINANCE U.S. LLC Subsidiary · Wilmington, Delaware, United States
- Innospec Holding do Brasil Ltda Subsidiary · Brazil
- INNOSPEC LEUNA GMBH Subsidiary · Leuna, Germany
- Innospec Performance Chemicals Europe Limited (U.K.) Innospec Performance Chemicals Spain S.L. (Spain) Innospec Performance Chemicals Italia s.r.l (Italy) Innospec Saint-Mihiel SAS Subsidiary · France
- Innospec Performance Chemicals France SA (France) Innospec Canada Limited Subsidiary · Canada
- Innospec Saudi Arabia Company Subsidiary · Saudi Arabia
- QGP Química Geral S.A. Subsidiary · Brazil
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Innospec reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $712.2M8 Dec 31, 2025 | $612.0M8 Dec 31, 2024 | +16.4% |
| Accumulated depreciation | $426.1M8 Dec 31, 2025 | $342.3M8 Dec 31, 2024 | +24.5% |
| Property and equipment, net | $286.1M8 Dec 31, 2025 | $269.7M8 Dec 31, 2024 | +6.1% |
| Operating-lease assets (leased space) | $52.7M8 Dec 31, 2025 | $44.8M8 Dec 31, 2024 | +17.6% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $292.5M8 Dec 31, 2025 | $289.2M8 Dec 31, 2024 | +1.1% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $399.0M8 Dec 31, 2025 | $382.5M8 Dec 31, 2024 | +4.3% |
| Intangible assets, net (excluding goodwill) | $67.7M8 Dec 31, 2025 | $65.4M8 Dec 31, 2024 | +3.5% |
| Finite-lived intangibles, gross | $373.3M8 Dec 31, 2025 | $331.9M8 Dec 31, 2024 | +12.5% |
| Accumulated amortization | -$305.6M8 Dec 31, 2025 | -$266.5M8 Dec 31, 2024 | −14.7% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $329.3M8 Dec 31, 2025 | $301.0M8 Dec 31, 2024 | +9.4% |
| Raw materials | $103.0M8 Dec 31, 2025 | $103.1M8 Dec 31, 2024 | −0.1% |
| Finished goods | $226.3M8 Dec 31, 2025 | $197.9M8 Dec 31, 2024 | +14.4% |
Properties, in its own words
General
A summary of the Company’s principal properties is shown in the following table. Each of these properties is owned by the Company except where otherwise noted:
The rest of Item 2
Location · Reporting Segment · Operations
Englewood, Colorado (1) · Fuel Specialties · Corporate Headquarters/Business Teams/Sales/Administration
Newark, Delaware (1) · Fuel Specialties · Research & Development
Herne, Germany · Fuel Specialties · Sales/Manufacturing/Administration/Research & Development
Vernon, France · Fuel Specialties · Sales/Manufacturing/Administration/Research & Development
Leuna, Germany · Fuel Specialties · Sales/Manufacturing/Administration/Research & Development
Ellesmere Port, United Kingdom · Fuel Specialties, Performance Chemicals and Oilfield Services · European Headquarters/Business Teams/Sales/Manufacturing/Administration/Research & Development/Fuel Technology Center
Beijing, China (1) · Fuel Specialties and Performance Chemicals · Sales/Administration
Shanghai, China (1) · Fuel Specialties and Performance Chemicals · Sales/Administration
Singapore, Singapore (1) · Fuel Specialties and Performance Chemicals · Asia-Pacific Headquarters/Business Teams/Sales/Administration
Milan, Italy (1) · Fuel Specialties and Performance Chemicals · Sales/Administration
Rio de Janeiro, Brazil (1) · Fuel Specialties, Performance Chemicals and Oilfield Services · Sales/Administration
São Paulo, Brazil · Performance Chemicals · Manufacturing/Administration/Research & Development
High Point, North Carolina · Performance Chemicals · Manufacturing/Administration/Research & Development
Salisbury, North Carolina · Performance Chemicals · Manufacturing/Administration/Research & Development
Chatsworth, California (1) · Performance Chemicals · Sales/Manufacturing/Administration
Saint Mihiel, France · Performance Chemicals · Manufacturing/Administration/Research & Development
Castiglione, Italy · Performance Chemicals · Manufacturing/Administration/Research & Development
Barcelona, Spain (1) · Performance Chemicals · Manufacturing/Administration/Research & Development
Location · Reporting Segment · Operations
Oklahoma City, Oklahoma · Oilfield Services · Sales/Manufacturing/Administration
Midland, Texas · Oilfield Services · Sales/Manufacturing/Administration
Pleasanton, Texas · Oilfield Services · Sales/Manufacturing/Administration
Sugar Land, Texas (1) · Oilfield Services · Sales/Administration/Research & Development
The Woodlands, Houston, Texas (1) · Oilfield Services · Sales/Administration/Research & Development
Williston, North Dakota · Oilfield Services · Sales/Warehouse
Casper, Wyoming (1) · Oilfield Services · Warehouse
Al-Khobar, Kingdom of Saudi Arabia (1) · Oilfield Services · Sales/Warehouse/Administration
Leased property
Manufacturing Capacity
We believe that our plants and supply agreements are sufficient to meet current sales levels. Operating rates of the plants are generally flexible and varied with product mix and normal sales demand swings. We believe that all of our facilities are maintained to appropriate levels and in sufficient operating condition though there remains an ongoing need for maintenance and capital investment.
Item 2 of the 10-K filed Feb 18, 2026.16
Leadership
Who has led Innospec, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerPatrick Williams Feb 18, 2014 to now17
- PresidentPatrick Williams Feb 25, 2015 to now18
- Chief financial officerIan Cleminson Jul 6, 2006 to now19
Board members and other officers (31)
- SVP, Corporate Dev and IRCorbin Barnes May 12, 2021 to now20
- SVP, HUMAN RESOURCESHardy Louis Griffin Iii. May 14, 2021 to now21
- Head of Group FinanceGraeme Blair Jul 1, 2020 to now22
- VP, GC & CCOBentley Jones David Feb 6, 2018 to now23
- Group Financial ControllerPhilip Curran Feb 25, 2015 to Feb 28, 202024
- EVP & PRESIDENT FS AMERICASPatrick Joseph McDuff May 20, 2015 to Mar 18, 201625
- VP, Strategic PlanningBrian Watt May 18, 2011 to May 13, 202126
- Exec VP, Business OperationsPhilip John Boon Jun 2, 2009 to now27
- Exec VP & President, Pet SpecsPatrick Williams Feb 9, 2006 to May 10, 201328
- Senior VP - Human ResourcesCatherine Hessner Feb 14, 2006 to May 13, 202129
- Snr VP Research & TechnologyIan Malcolm McRobbie Feb 14, 2006 to now30
- Group Financial ControllerNeale Perrins Feb 14, 2006 to Feb 14, 200631
- VP Safety, Health & Env.Richard Tudor Shone Mar 24, 2006 to May 19, 200832
- Board memberShelley J. Bausch Jul 1, 2026 to now33
- Board memberLeslie J. Parrette Jan 19, 2022 to now34
- Board memberElizabeth K. Arnold Nov 3, 2020 to now35
- Board memberClaudia Poccia Jul 31, 2019 to now36
- Board memberDavid Landless Feb 19, 2016 to now37
- Board memberLarry Padfield Jan 24, 2013 to now38
- Board memberMilton C. Blackmore Oct 8, 2010 to now39
- Board memberRobert I. Paller Nov 13, 2009 to Feb 28, 202440
- Board memberJoachim Roeser Dec 18, 2007 to Feb 26, 202041
- Board memberPeter Fearn Dec 20, 2007 to Mar 26, 200942
- Board memberCharles M. Hale Feb 14, 2006 to Mar 7, 200843
- Board memberHugh Aldous Feb 14, 2006 to Feb 26, 202044
- Board memberJames Martin Combe Puckridge Feb 14, 2006 to Feb 19, 201045
- Board memberMartin Demora Hale Feb 14, 2006 to Feb 24, 201646
- Board memberPaul Willis Jennings Feb 14, 2006 to May 20, 200947
- Board memberRobert Ernest Bew Feb 14, 2006 to May 24, 201248
- Board memberSamuel Allen Haubold Feb 14, 2006 to Mar 7, 200849
- General counselAndrew Hartley Feb 14, 2006 to Mar 7, 201250
Products and brands
- specialty chemicals
Listed on Wikidata.1
Locations
Innospec is headquartered in Englewood, Colorado, and has major regional centers in the United Kingdom and Singapore, along with international offices and processing facilities.
Production plants are located in multiple countries including UK, France, Germany, Philippines, the United States, Italy and Spain.
The company has around 2,000 employees located in 20 countries.
Products
Innospec markets detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, antioxidants, cetane improvers, TEL, and a range of other chemicals as fuel additives.
Read the full text
The Oilfield Services division provides products and services for drilling, fracturing & stimulation and production operations to the oil and gas industry
In Personal Care, the company makes a range of surfactants, emollients and silicone formulations.
From Wikipedia’s article on Innospec, shared under CC BY-SA 4.0.6
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Innospec Active Chemicals LLC (USA) Innospec Deutschland GmbH (Germany) Innospec Finance Limited (U.K.) Innospec Finance U.S. LLC (USA) Innospec France SA France7
- Innospec Chemicals (Shanghai) Limited China7
- Innospec Chemicals Beijing Limited China7
- Innospec Do Brasil Limited Brazil7
- Innospec Holding do Brasil Ltda Brazil7
- Innospec Performance Chemicals Europe Limited (U.K.) Innospec Performance Chemicals Spain S.L. (Spain) Innospec Performance Chemicals Italia s.r.l (Italy) Innospec Saint-Mihiel SAS France7
- Innospec Performance Chemicals France SA (France) Innospec Canada Limited Canada7
- Innospec Saudi Arabia Company Saudi Arabia7
- QGP Química Geral S.A. Brazil7
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Acquisitions
Innospec has made the following recent acquisitions and divestments:
Strata Control was acquired in December 2013 in Oilfield Drilling Specialties.
Chemsil Silicones and Chemtec were acquired in September 2013 in Personal Care.
Bachman Services was acquired in November 2013 in Oilfield Production Specialties.
Read the full text
Independence Oilfield Chemicals was acquired in November 2014 in Oilfield Chemicals.
Innospec divested its Aroma Chemicals business to Emerald Kalama in July 2015.
As of January 1, 2016; Bachman, Strata and Independence Oilfield Chemicals have been reorganized into one company, Innospec Oilfield Specialties.
On January 3, 2017, Innospec announced it had completed the acquisition of the European Differentiated Surfactants business from Huntsman
From Wikipedia’s article on Innospec, shared under CC BY-SA 4.0.6
Former names
- OCTEL CORPJun 9, 1998 to Jan 9, 20065
Timeline
- Aug 5, 20268-K Results of operations51
- Jun 4, 20268-K Executive or director change52
- May 13, 20268-K Shareholder vote53
- May 8, 20268-K Results of operations; Regulation FD disclosure54
- Feb 18, 20268-K Results of operations55
- Nov 5, 20258-K Results of operations; Regulation FD disclosure56
- Aug 6, 20258-K Results of operations57
- May 14, 20258-K Shareholder vote58
- May 9, 20258-K Results of operations; Regulation FD disclosure59
- Mar 11, 20258-K Regulation FD disclosure60
- Feb 19, 20258-K Results of operations61
- Nov 6, 20248-K Results of operations; Regulation FD disclosure62
- Feb 18, 2014New chief executive Patrick Williams becomes CEO17
- 1999Founded Founded1
Calendar
Coming up
- Nov 3, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.12 a share, on Nov 4, 2025.63
When it reported results
- Aug 5, 2026Reported quarterly or annual results51
- May 8, 2026Reported quarterly or annual results54
- Feb 18, 2026Reported quarterly or annual results55
- Nov 5, 2025Reported quarterly or annual results56
- Aug 6, 2025Reported quarterly or annual results57
- May 9, 2025Reported quarterly or annual results59
- Feb 19, 2025Reported quarterly or annual results61
- Nov 6, 2024Reported quarterly or annual results62
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
282 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 179 insider forms, 30 large holders, 19 other. The latest 20:
- Oct 7, 2026SCHEDULE 13G/A EDGAR
- Oct 7, 2026SCHEDULE 13G EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Jul 31, 2026SCHEDULE 13G/A EDGAR
- Jul 14, 2026SCHEDULE 13G EDGAR
- Jul 1, 20263 EDGAR
- Jun 4, 20268-K EDGAR
- May 29, 2026SD EDGAR
- May 13, 20268-K EDGAR
- May 8, 202610-Q EDGAR
- May 8, 20268-K EDGAR
- Apr 30, 2026SCHEDULE 13G EDGAR
- Apr 29, 2026SCHEDULE 13G EDGAR
The 282 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
67 open-market trades by officers, directors and large owners since October 2021: 10 buys and 57 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Jones David B.SVP, GC & CCO | Sale | 1,028 | $75.64 | $77.8K | Form 4 |
| Feb 27, 2026 | Blackmore Milton CDirector | Sale | 594 | $76.55 | $45.5K | Form 4 |
| Feb 27, 2026 | PADFIELD LarryDirector | Sale | 594 | $76.55 | $45.5K | Form 4 |
| Feb 27, 2026 | Poccia ClaudiaDirector | Sale | 119 | $76.56 | $9.1K | Form 4 |
| Feb 27, 2026 | LANDLESS DAVIDDirector | Sale | 594 | $76.55 | $45.5K | Form 4 |
| Feb 27, 2026 | Cleminson IanEVP & CFO | Sale | 2,380 | $76.55 | $182.2K | Form 4 |
| Feb 27, 2026 | Blackmore Milton CDirector | Sale | 594 | $76.56 | $45.5K | Form 4 |
| Feb 27, 2026 | PADFIELD LarryDirector | Sale | 594 | $76.56 | $45.5K | Form 4 |
| Feb 27, 2026 | Poccia ClaudiaDirector | Sale | 119 | $76.56 | $9.1K | Form 4 |
| Feb 27, 2026 | LANDLESS DAVIDDirector | Sale | 594 | $76.56 | $45.5K | Form 4 |
| Feb 27, 2026 | Cleminson IanEVP & CFO | Sale | 2,380 | $76.56 | $182.2K | Form 4 |
| Feb 20, 2026 | Blackmore Milton CDirector | Sale | 1,030 | $81.84 | $84.3K | Form 4 |
| Feb 20, 2026 | PADFIELD LarryDirector | Sale | 1,030 | $81.84 | $84.3K | Form 4 |
| Nov 14, 2025 | PARRETTE LESLIE JDirector | Buy | 340 | $74.09 | $25.2K | Form 4 |
| May 13, 2025 | PARRETTE LESLIE JDirector | Sale | 446 | $90.63 | $40.4K | Form 4 |
| Mar 3, 2025 | Cleminson IanEVP & CFO | Sale | 4,275 | $100.98 | $431.7K | Form 4 |
| Feb 24, 2025 | BARNES CORBINSVP, Corporate Dev and IR | Sale | 598 | $103.06 | $61.6K | Form 4 |
| Feb 21, 2025 | PADFIELD LarryDirector | Sale | 196 | $103.30 | $20.2K | Form 4 |
| Feb 21, 2025 | BOON PHILIP JOHNExecutive VP Business Ops | Sale | 3,754 | $103.30 | $387.8K | Form 4 |
| Feb 21, 2025 | BARNES CORBINSVP, Corporate Dev and IR | Sale | 2,692 | $103.30 | $278.1K | Form 4 |
All 67 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Allspring Global Investments Holdings, LLCSCHEDULE 13G/A, 8 filings Jan 18, 2022 to Oct 7, 202664
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G, 2 filings Feb 8, 2022 to Jul 14, 202665
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202666
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202667
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202668
- WASATCH ADVISORS LPSCHEDULE 13G/A, 4 filings Feb 8, 2023 to May 13, 202569
- BlackRockSCHEDULE 13G/A, 6 filings Jan 26, 2022 to Apr 30, 202570
- ROYCE & ASSOCIATES LPSC 13G/A, 2 filings Jan 21, 2022 to Jan 31, 202371
- Wells FargoSC 13G/A, 2 filings Nov 10, 2021 to Dec 8, 202172
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Mr. Patrick S. WilliamsPresident and Chief Executive Officer | $1.4M | $8.3M73 | |
| 2025 | Mr. Ian P. CleminsonExecutive Vice President and Chief Financial Officer | $541.1K | $2.0M73 | |
| 2025 | Mr. David B. JonesSenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | $425.0K | $1.4M73 | |
| 2025 | Mr. Corbin BarnesSenior Vice President, Corporate Development and Investor Relations | $342.7K | $1.2M73 | |
| 2025 | Dr. Ian M. McRobbieSenior Vice President and Chief Technology Officer | $309.6K | $1.1M73 | |
| 2024 | Mr. Patrick S. WilliamsPresident and Chief Executive Officer | $1.4M | $13.2M73 | |
| 2024 | Mr. Ian P. CleminsonExecutive Vice President and Chief Financial Officer | $497.2K | $3.1M73 | |
| 2024 | Mr. David B. JonesSenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | $349.2K | $1.9M73 | |
| 2024 | Mr. Corbin BarnesSenior Vice President, Corporate Development and Investor Relations | $314.2K | $1.6M73 | |
| 2023 | Mr. Patrick S. WilliamsPresident and Chief Executive Officer | $1.4M | $7.3M73 | |
| 2023 | Mr. Ian P. CleminsonExecutive Vice President and Chief Financial Officer | $427.9K | $1.5M73 | |
| 2023 | Mr. David B. JonesSenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | $348.5K | $1.2M73 | |
| 2023 | Mr. Corbin BarnesSenior Vice President, Corporate Development and Investor Relations | $313.8K | $1.0M73 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 4,381,323 | $356.6M | 0.0% | +502,348 |
| Allspring Global Investments Holdings, LLC | 1,892,471 | $154.7M | 0.2% | −423,471 |
| Vanguard Portfolio Management LLC | 1,884,244 | $153.4M | 0.0% | +24,153 |
| Dimensional Fund Advisors LP | 1,305,038 | $106.2M | 0.0% | +62,949 |
| Vanguard Capital Management LLC | 1,108,107 | $90.2M | 0.0% | −6,491 |
| State Street Corp | 996,027 | $81.1M | 0.0% | +31,692 |
| Nuveen, LLC | 755,723 | $61.5M | 0.0% | +112,475 |
| Geode Capital Management, LLC | 666,589 | $54.3M | 0.0% | +35,997 |
| Goldman Sachs Group Inc | 662,210 | $53.9M | 0.0% | +170,199 |
| Victory Capital Management Inc | 660,110 | $53.7M | 0.0% | −204,884 |
| Two Sigma Investments, LP | 568,709 | $46.3M | 0.0% | −24,330 |
| Assenagon Asset Management S.A. | 545,564 | $44.4M | 0.0% | +54,680 |
| Aqr Capital Management LLC | 482,545 | $39.3M | 0.0% | +170,480 |
| Brown Advisory Inc | 408,468 | $33.2M | 0.1% | +112,003 |
| Jpmorgan Chase & Co | 370,574 | $30.0M | 0.0% | −55,476 |
| Charles Schwab Investment Management Inc | 355,658 | $28.9M | 0.0% | −10,216 |
| Gendell Jeffrey L | 324,504 | $26.4M | 0.2% | +30,000 |
| Royce & Associates LP | 308,726 | $25.1M | 0.2% | +47,390 |
| Northern Trust Corp | 303,044 | $24.7M | 0.0% | +18,805 |
| Qube Research & Technologies Ltd | 285,849 | $23.3M | 0.0% | −120,775 |
| Western Standard LLC | 236,833 | $19.3M | 6.5% | +10,000 |
| Bank Of America Corp /de/ | 235,742 | $19.2M | 0.0% | −55,024 |
| Morgan Stanley | 230,793 | $18.8M | 0.0% | −4,778 |
| Renaissance Technologies LLC | 185,000 | $15.1M | 0.0% | +66,100 |
| Panagora Asset Management Inc | 182,538 | $14.9M | 0.0% | +62,863 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Innospec is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARINNOSPEC INC.2
- CIK0001054905
- Employer ID (EIN)98-018172516
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company16
- Incorporated inDelaware16
- Fiscal year endsDecember 312
- Industry code (SIC)2800 Chemicals & Allied Products2
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
- Business address8310 South Valley Highway, Suite 350, Englewood, CO 801122
- Phone72035564512
- Shares outstanding24,631,047 as of Jul 31, 202614
- Public float$1.3B as of Jun 30, 202516
- AuditorPricewaterhouseCoopers LLP, Manchester, United Kingdom PCAOB ID 876; it also attests to the company’s internal control over financial reporting16
- On EDGAR sinceFeb 13, 19982
- Filings1,769 in all: 4 (978), 8-K (241), SC 13G/A (115), 4/A (88), 10-Q (86), 3 (32), 10-K (28), DEF 14A (28)2
All 35 form types
SC 13G (28), UPLOAD (24), CORRESP (21), DEFA14A (20), SC 13D/A (14), ARS (10), SD (10), 5 (6), S-8 (6), SCHEDULE 13G/A (6), 8-K/A (5), SCHEDULE 13G (4), 10-12B/A (3), 10-12B (2), SC 13D (2), 10-Q/A (1), 15-12B (1), 25 (1), 3/A (1), 8-A12B (1), 8-A12G (1), NT 10-K (1), NT 10-Q (1), RW (1), S-4 (1), S-4/A (1), S-8 POS (1)
- Latest filingsAnnual report (10-K) Feb 18, 2026
Quarterly report (10-Q) Aug 5, 2026
Proxy statement (DEF 14A) Mar 26, 2026
Latest 8-K (8-K) Aug 5, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common stock | IOSP | NASDAQ |
From the cover page of the 10-K filed Feb 18, 2026 (Section 12(b) of the Exchange Act).16
Risk factors and legal proceedings
The risks Innospec names in Item 1A of its 10-K filed Feb 18, 2026: 27 risks under these headings, as written.16
- Global Conditions
- Competition and market conditions may adversely affect our operating results.
- Continuing adverse global economic conditions could materially affect our current and future businesses.
- Domestic or international natural disasters or terrorist attacks may disrupt our operations, decrease the demand for our products or otherwise have an adverse impact on our business.
- Our business and operations have been, and may in the future be, adversely affected by epidemics, pandemics, outbreaks of disease and other adverse public health developments, including coronaviruses.
- Business Operations
- We face risks related to our foreign operations that may adversely affect our business.
- We may not be able to consummate, finance or successfully integrate future acquisitions, partnerships or other opportunities into our business, which could hinder our strategy or result in unanticipated expenses and losses.
- Our success depends on our management team and other key personnel, the loss of any of whom could disrupt our business operations.
- An information technology system failure may adversely affect our business.
- Our ability to monitor and manage our business performance is dependent upon the effectiveness of our information technology systems.
- Decline in our AvGas business.
The other 17 risks
- Failure to protect our intellectual property rights could adversely affect our future performance and cash flows.
- Industry Matters
- Trends in oil and gas prices affect the level of exploration, development and production activity of our customers, and the demand for our services and products, which could have a material adverse impact on our business.
- We could be adversely affected by technological changes in our industry.
- Sharp and unexpected fluctuations in the cost of our raw materials and energy could adversely affect our profit margins.
- Legal, Regulatory and Tax Matters
- We are subject to extensive regulation of our international operations that could adversely affect our business and results of operations.
- We may have additional tax liabilities.
- Our products are subject to extensive government scrutiny and regulation.
- Legal proceedings and other claims could impose substantial costs on us.
- Environmental liabilities and compliance costs could have a substantial adverse impact on our results of operations.
- We may be exposed to certain regulatory and financial risks related to climate change.
- Key Third-Party Relationships
- Having a small number of significant customers may have a material adverse impact on our results of operations.
- A disruption in the supply of raw materials or transportation services would have a material adverse impact on our results of operations.
- The inability of counterparties to meet their contractual obligations could have a substantial adverse impact on our results of operations.
- Finance and Investment
- We are exposed to fluctuations in foreign currency exchange rates, which may adversely affect our results of operations.
- A high concentration of significant stockholders may have a material adverse impact on our stock price.
- Our amended and restated by-laws designate specific Delaware courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
- The provisions of our revolving credit facility may restrict our ability to incur additional indebtedness or to otherwise expand our business.
Legal proceedings
Legal matters
We are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, and employee and product liability claims.
As reported in the 2023 Form 10-K, we have incurred financial losses and lodged a civil and criminal legal claim related to a misappropriation of inventory in Brazil. At the time of filing, there have been no significant developments to report in relation to the claims being made. Consistent with prior quarters, a corresponding asset for the potential legal or insurance recoveries has not been recorded for the resulting financial losses arising from this matter.
In addition, unrelated to the Brazil matter, in the unlikely event there are an unexpectedly large number of individual claims or proceedings with an adverse resolution, this could in the aggregate have a material adverse effect on the results of operations for a particular year or quarter.
The opening of Item 3, Legal Proceedings.16
Links
- Websitewww.innospecinc.com1
- WikipediaInnospec
- WikidataQ15109891
- SEC EDGARCIK 1054905
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataInnospec on Wikidata
- 2SEC EDGARInnospec filings on SEC EDGAR
- 3WikipediaInnospec on Wikipedia
- 4
- 5SEC EDGARInnospec filings on SEC EDGAR
- 6
- 7
- 8SEC EDGARInnospec 10-K for fiscal 2025
- 9SEC EDGARInnospec 10-K for fiscal 2019
- 10SEC EDGARInnospec 10-K for fiscal 2020
- 11SEC EDGARInnospec 10-K for fiscal 2021
- 12SEC EDGARInnospec 10-K for fiscal 2022
- 13SEC EDGARInnospec 10-Q for fiscal 2026
- 14SEC EDGARInnospec 10-Q for fiscal 2026
- 15SEC EDGARInnospec 10-K for fiscal 2019
- 16
- 17
- 18SEC EDGARPatrick Williams, President
- 19
- 20
- 21
- 22SEC EDGARGraeme Blair, Head of Group Finance
- 23SEC EDGARBentley Jones David, VP, GC & CCO
- 24
- 25
- 26SEC EDGARBrian Watt, VP, Strategic Planning
- 27
- 28
- 29
- 30
- 31
- 32
- 33SEC EDGARShelley J. Bausch, Board member
- 34SEC EDGARLeslie J. Parrette, Board member
- 35SEC EDGARElizabeth K. Arnold, Board member
- 36SEC EDGARClaudia Poccia, Board member
- 37SEC EDGARDavid Landless, Board member
- 38SEC EDGARLarry Padfield, Board member
- 39SEC EDGARMilton C. Blackmore, Board member
- 40SEC EDGARRobert I. Paller, Board member
- 41SEC EDGARJoachim Roeser, Board member
- 42SEC EDGARPeter Fearn, Board member
- 43SEC EDGARCharles M. Hale, Board member
- 44SEC EDGARHugh Aldous, Board member
- 45
- 46SEC EDGARMartin Demora Hale, Board member
- 47SEC EDGARPaul Willis Jennings, Board member
- 48SEC EDGARRobert Ernest Bew, Board member
- 49SEC EDGARSamuel Allen Haubold, Board member
- 50SEC EDGARAndrew Hartley, General counsel
- 51SEC EDGARResults of operations
- 52SEC EDGARExecutive or director change
- 53SEC EDGARShareholder vote
- 54
- 55SEC EDGARResults of operations
- 56
- 57SEC EDGARResults of operations
- 58SEC EDGARShareholder vote
- 59
- 60SEC EDGARRegulation FD disclosure
- 61SEC EDGARResults of operations
- 62
- 63NasdaqNasdaq calendar
- 64
- 65
- 66
- 67
- 68
- 69
- 70SEC EDGARBlackRock SCHEDULE 13G/A on Innospec
- 71
- 72SEC EDGARWells Fargo SC 13G/A on Innospec
- 73